Skip to main content
SpringerLink
Log in

Parkinson’s Disease and Movement Disorders: Historical and Ethical Perspectives

  • Reference work entry
  • First Online:
Handbook of Neuroethics

  • 274 Accesses

Abstract

Therapeutic interventions employed in the management of extrapyramidal movement disorders have the potential to modify behavior, mood, and personality by virtue of the fact that the basal ganglia and dopaminergic neural systems affected by these disorders are also intimately involved in cognitive, emotional, and behavioral processes. The ethical implications of this situation, however, have received widespread attention only in recent years. Despite the sometimes negative changes in behavior that may ensue, the indubitable liberating motor benefits of dopamine replacement therapy employed to treat Parkinson’s disease and the associated increase in personal freedom for the patient justify its employment. Neurotransplantation may in the future prove to be a useful approach that avoids such problems, but the current absence of a safe procedure militates against its use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albin, R. L. (2002). Sham surgery controls: Intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls. Journal of Medical Ethics, 28, 322–325.

    Article  Google Scholar 

  • Appel-Cresswell, S., & Stoessl, A. J. (2011). Ethical issues in the management of Parkinson’s disease. In J. Illes & B. J. Sahakian (Eds.), The Oxford handbook of neuroethics (pp. 575–600). Oxford: Oxford University Press.

    Google Scholar 

  • Beauchamp, T. L., & Childress, J. F. (1994). Principles of biomedical ethics. New York: Oxford University Press.

    Google Scholar 

  • Bell, E., Maxwell, B., McAndrews, M. P., Sadikot, A. F., & Racine, E. (2011). A review of social and relational aspects of deep brain stimulation in Parkinson’s disease informed by healthcare provider experiences. Parkinson’s Disease, 2011, ID 871874 (8pp.).

    Google Scholar 

  • Bleuler, E. (1911). Dementia praecox, oder Gruppe der Schizophrenien. Leipzig, Wien: Franz Deuticke.

    Google Scholar 

  • Bodi, N., Keri, S., Nagy, H., Moustafa, A., Daw, N., Dibo, G., Takats, A., Bereczki, D., & Gluck, M. A. (2009). Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain, 132, 2385–2395.

    Article  Google Scholar 

  • Bonnet, A. M., Jutras, M. F., Czernecki, V., Corvol, J. C., & Vidailhet, M. (2012). Nonmotor symptoms in Parkinson’s disease in 2012: Relevant clinical aspects. Parkinson’s Disease, 2012, 198316 (15pp.).

    Google Scholar 

  • Bostroem, A. (1922). Der amyostatische Symptomenkomplex. Klinische Untersuchungen unter Berücksichtigung allgemein-pathologischer Fragen. Berlin: Julius Springer.

    Google Scholar 

  • Brundin, P., Barker, R. A., & Parmar, M. (2010). Neural grafting in Parkinson’s disease: Problems and possibilities. Progress in Brain Research, 184, 265–294.

    Article  Google Scholar 

  • Carter, A., Ambermoon, P., & Hall, W. D. (2011). Drug-induced impulse control disorders: A prospectus for neuroethical analysis. Neuroethics, 4, 91–102.

    Article  Google Scholar 

  • Cilia, R., & van Eimeren, T. (2011). Impulse control disorders in Parkinson’s disease: Seeking a roadmap toward a better understanding. Brain Structure & Function, 216, 289–299.

    Article  Google Scholar 

  • Dekkers, W., & Boer, G. (2001). Sham neurosurgery in patients with Parkinson’s disease: Is it morally acceptable? Journal of Medical Ethics, 27, 151–156.

    Article  Google Scholar 

  • Doshay, L. J. (1965). Problems in Parkinson’s disease confronting the profession and the community. In A. Barbeau, L. J. Doshay, & E. A. Spiegel (Eds.), Parkinson’s disease. Trends in research and treatment (pp. 1–5). New York: Grune & Stratton.

    Google Scholar 

  • Dunnett, S. B. (2010). Neural transplantation. In S. Finger, F. Bolle, & K. L. Tyler (Eds.), History of neurology (Handbook of clinical neurology, Vol. 3, pp. 885–912). Elsevier: Edinburgh. Vol. 95.

    Google Scholar 

  • Fins, J. J. (2009). Deep brain stimulation, deontology and duty: The moral obligation of non-abandonment at the neural interface. Journal of Neural Engineering, 6, 050201 (4pp.).

    Article  Google Scholar 

  • Fleck, U. (1927a). Über die psychischen Veränderungen der erwachsenen Metencephalitiker mit Betrachtungen über die psychischen Folgezustände der Encephalitis epidemica überhaupt. Archiv für Psychiatrie und Nervenkrankheiten, 80, 297–311.

    Article  Google Scholar 

  • Fleck, U. (1927b). Über die psychischen Folgezustände nach Encephalitis epidemica bei Jugendlichen. Archiv für Psychiatrie und Nervenkrankheiten, 79, 723–785.

    Article  Google Scholar 

  • Foley, P. B. (2003). Beans, roots and leaves. A history of the chemical therapy of parkinsonism. Marburg: Tectum.

    Google Scholar 

  • Foley, P. (2009). Dopamine in perspective. In L. Squire (Ed.), New encyclopedia of neuroscience (pp. 563–570). Oxford: Academic.

    Chapter  Google Scholar 

  • Foley, P. (2012). The encephalitis lethargica patient as a window on the soul. In L. S. Jacyna & S. T. Casper (Eds.), The neurological patient in history (pp. 184–211). Rochester: University of Rochester Press.

    Chapter  Google Scholar 

  • Frank, S. A., Wilson, R., Holloway, R. G., Zimmerman, C., Peterson, D. R., Kieburtz, K., & Kim, S. Y. H. (2008). Ethics of sham surgery: Perspective of patients. Movement Disorders, 23, 63–68.

    Article  Google Scholar 

  • Freed, C. R., Zhou, W., & Breeze, R. E. (2011). Dopamine cell transplantation for Parkinson’s disease: The importance of controlled clinical trials. Neurotherapeutics, 8, 549–561.

    Article  Google Scholar 

  • Galpern, W. R., Corrigan-Curay, J., Lang, A. E., Kahn, J., Tagle, D., Barker, R. A., Freeman, T. B., Goetz, C. G., Kieburtz, K., Kim, S. Y., Piantadosi, S., Comstock Rick, A., & Federoff, H. J. (2012). Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: Scientific and ethical considerations. Lancet Neurology, 11, 643–650.

    Article  Google Scholar 

  • Goetz, C. G., Bonduelle, M., & Gelfand, T. (1995). Charcot. Constructing neurology. Oxford/New York: Oxford University Press.

    Google Scholar 

  • Guillain, G., & Mollaret, P. (1932). Les séquelles de l’encéphalite épidémique. Étude clinique et thérapeutique. Paris: G. Doin & Cie.

    Google Scholar 

  • Jankovic, J., & Poewe, W. (2012). Therapies in Parkinson’s disease. Current Opinion in Neurology, 25, 433–447.

    Article  Google Scholar 

  • Kimmelman, J., London, A. J., Ravina, B., Ramsay, T., Bernstein, M., Fine, A., Stahnisch, F. W., & Emborg, M. E. (2009). Launching invasive, first-in-human trials against Parkinson’s disease: Ethical considerations. Movement Disorders, 24, 1893–1901.

    Article  Google Scholar 

  • Lindvall, O., & Björklund, A. (2011). Cell therapeutics in Parkinson’s disease. Neurotherapeutics, 8, 539–548.

    Article  Google Scholar 

  • Linke, D. B. (1993). Hirnverpflanzung. Die erste Unsterblichkeit auf Erden. Reinbek bei Hamburg: Rowohlt.

    Google Scholar 

  • Lotmar, F. (1926). Die Stammganglien und die extrapyramidal-motorischen Syndrome. Berlin: Julius Springer.

    Book  Google Scholar 

  • Makowski, J. H. (1983). Contribution à l’étude des malades mentaux dangereux: itinéraire médico légal et psychiatrique de 1926 à 1982 d’un malade présentant des séquelles d’encéphalite épidémique, ou maladie de Von Economo-Cruchet. Thesis, Paris.

    Google Scholar 

  • Master, Z., McLeod, M., & Mendez, I. (2007). Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease. Journal of Medical Ethics, 33, 169–173.

    Article  Google Scholar 

  • Mauron, A., & Hurst, S. (2010). Experimenting innovative cell therapies for Parkinson’s disease: A view from ethics. In H. Fangerau, H. Fangerau, & T. Trapp (Eds.), Implanted minds. The neuroethics of intracerebral stem cell transplantation and deep brain stimulation (pp. 107–122). Bielefeld: Transcript.

    Google Scholar 

  • Moreira, T., & Palladino, P. (2005). Between truth and hope: On Parkinson’s disease, neurotransplantation and the production of the ‘self’. History of the Human Sciences, 18, 55–82.

    Article  Google Scholar 

  • Neustadt, R. (1932). Die chronische Encephalitis epidemica in ihrer gutachtlichen und sozialen Bedeutung. Leipzig: Johann Ambrosius Barth.

    Google Scholar 

  • Northoff, G. (1996). Do brain tissue transplants alter personal identity? Inadequacies of some “standard” arguments. Journal of Medical Ethics, 22, 174–180.

    Article  Google Scholar 

  • Northoff, G. (2004). The influence of brain implants on personal identity and personality – a combined theoretical and empirical investigation in ‘neuroethics’. In T. Schramme & J. Thome (Eds.), Philosophy and psychiatry (pp. 326–344). Berlin: Walter de Gruyter.

    Google Scholar 

  • O’Sullivan, S. S., Evans, A. H., & Lees, A. J. (2009). Dopamine dysregulation syndrome. An overview of its epidemiology, mechanisms and management. CNS Drugs, 23, 157–170.

    Article  Google Scholar 

  • Politis, M., & Lindvall, O. (2012). Clinical application of stem cell therapy in Parkinson’s disease. BMC Medicine, 10, 1 (7pp).

    Article  Google Scholar 

  • Rabins, P., Appleby, B. S., Brandt, J., DeLong, M. R., Dunn, L. B., Gabriëls, L., Greenberg, B. D., Haber, S. N., Holtzheimer, P. E., Mari, Z., Mayberg, H. S., McCann, E., Mink, S. P., Rasmussen, S., Schlaepfer, T. E., Vawter, D. E., Vitek, J. L., Walkup, J., & Mathews, D. J. H. (2009). Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Archives of General Psychiatry, 66, 931–937.

    Article  Google Scholar 

  • Raja, M., & Bentivoglio, A. R. (2012). Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson’s disease and other disorders. Current Drug Safety, 7, 63–75.

    Article  Google Scholar 

  • Reichardt, M. (1928). Hirnstamm und Psychiatrie. Monatsschrift für Psychiatrie und Neurologie, 68, 470–506.

    Article  Google Scholar 

  • Rosin, H. (1930). Über die Behandlung des Parkinsonismus mit Striaphorin. Deutsche Medizinische Wochenschrift, 56, 1046–1047.

    Article  Google Scholar 

  • Runge, W. (1928). Psychosen bei Gehirnerkrankungen. In: Die exogenen Reaktionsformen und die organischen Psychosen. (Handbuch der Geisteskrankheiten, Vol. 7. Spezieller Teil III, pp. 526–700). Berlin: Julius Springer.

    Google Scholar 

  • Schilder, P. (1922). Einige Bemerkungen zu der Problemsphäre: Cortex, Stammganglien — Psyche, Neurose. Zeitschrift für die gesamte Neurologie und Psychiatrie, 74, 454–481.

    Article  Google Scholar 

  • Steck, H. (1926). Les syndromes extrapyramidaux dans les maladies mentales. Archives Suisses de neurologie et de psychiatrie, 19, 195–233.

    Google Scholar 

  • Steck, H. (1927). Les syndromes extrapyramidaux dans les maladies mentales (suite et fin). Archives Suisses de neurologie et de psychiatrie, 20, 92–136.

    Google Scholar 

  • Steck, H. (1931). Les syndromes mentaux postencéphalitiques. Archives Suisses de neurologie et de psychiatrie, 27, 137–173.

    Google Scholar 

  • Stern, F. (1928). Die epidemische Encephalitis (2nd ed.). Berlin: Julius Springer.

    Book  Google Scholar 

  • Stertz, G. (1921). Der extrapyramidale Symptomenkomplex (das dystonische Syndrom) und seine Bedeutung in der Neurologie. Berlin: S. Karger.

    Google Scholar 

  • Strümpell, A. (1915). Zur Kenntnis der sog. Pseudosklerose, der Wilsonschen Krankheit und verwandter Krankheitszustände (der amyostatische Symptomenkomplex). Deutsche Zeitschrift für Nervenheilkunde, 54, 207–254.

    Article  Google Scholar 

  • Swift, T., & Huxtable, R. (2013). The ethics of sham surgery in Parkinson’s disease: Back to the future? Bioethics, 27, 175–185.

    Article  Google Scholar 

  • Thiele, R. (1926). Zur Kenntnis der psychischen Residuärzustände nach Encephalitis epidemica bei Kindern und Jugendlichen, insbesondere der Weiterentwicklung dieser Fälle. Berlin: S. Karger.

    Google Scholar 

  • Trillat, É. (1986). Histoire de l’hystérie. Paris: Seghers.

    Google Scholar 

  • Turner, T. H. (1992). A diagnostic analysis of the Casebooks of Ticehurst House Asylum, 1845–1890 (Psychological medicine. Monograph supplement, Vol. 21). Cambridge: Cambridge University Press.

    Google Scholar 

  • Vogt, C., & Vogt, O. (1919). Zur Kenntnis der pathologischen Veränderungen des Striatum und des Pallidum und zur Pathophysiologie der dabei auftretenden Krankheitserscheinungen. (Sitzungsberichte der Heidelberger Akademie der Wissenschaften. Mathematisch-Naturwissenschaftliche Klasse. Abteilung B. Biologische Wissenschaften, no. 14) (56pp).

    Google Scholar 

  • Volkow, N. D., Wang, G.-J., Fowler, J. S., & Tomasi, D. (2012). Addiction circuitry in the human brain. Annual Review of Pharmacology and Toxicology, 52, 321–336.

    Article  Google Scholar 

  • Voon, V., Mehta, A. R., & Hallett, M. (2011). Impulse control disorders in Parkinson’s disease: Recent advances. Current Opinion in Neurology, 24, 324–330.

    Article  Google Scholar 

  • Weintraub, D., & Burn, D. J. (2011). Parkinson’s disease: The quintessential neuropsychiatric disorder. Movement Disorders, 26, 1022–1031.

    Article  Google Scholar 

  • Weintraub, D., & Nirenberg, M. J. (2013). Impulse control and related disorders in Parkinson’s disease. Neurodegenerative Diseases, 11, 63–71.

    Article  Google Scholar 

  • Zingerle, H. (1936). Über subcorticale Anfälle. Deutsche Zeitschrift für Nervenheilkunde, 140, 113–168.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit for History and Philosophy of Science, University of Sydney, Hospital Road, Sydney, NSW, Australia

    Paul Foley

  2. Neuroscience Research Australia, Barker Street, 2031, Randwick, Sydney, NSW, Australia

    Paul Foley

Authors
  1. Paul Foley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Foley .

Editor information

Editors and Affiliations

  1. Institute for Ethics and History of Medicine, University of Tübingen, Tübingen, Germany

    Jens Clausen

  2. The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia

    Neil Levy

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this entry

Cite this entry

Foley, P. (2015). Parkinson’s Disease and Movement Disorders: Historical and Ethical Perspectives. In: Clausen, J., Levy, N. (eds) Handbook of Neuroethics. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4707-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-4707-4_23

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-4706-7

  • Online ISBN: 978-94-007-4707-4

  • eBook Packages: Humanities, Social Sciences and Law

Publish with us

Policies and ethics

Search

Navigation